project id: TCGA-LUAD; case submitter id: TCGA-55-7284; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; rna integrity number: 8.6; age at index: 74; days to birth: -27087; days to death: 243; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1937; age at diagnosis: 27087; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 121.0; icd 10 code: C34.8; last known disease status: not reported; morphology: 8252/3; primary diagnosis: Bronchiolo-alveolar carcinoma, non-mucinous; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of lung; synchronous malignancy: Yes; tissue or organ of origin: Overlapping lesion of lung; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 35.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.5; longest dimension: 0.9; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-55-7284-01B-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 80.0;